MADRIGAL PHARMACEUTICALS, INC. (7)

Browse by Contract Category

Contracts

Sales Agreement, dated June 1, 2021, by and between Madrigal Pharmaceuticals, Inc. and Cowen and Company, LLC (Filed With SEC on June 1, 2021)
Non-Employee Director Equity Compensation Policy (Filed With SEC on May 6, 2021)
Form of Nonqualified Stock Option Agreement for Directors under Amended 2015 Stock Plan (Filed With SEC on August 6, 2020)
Description of Securities of the Registrant (Filed With SEC on February 26, 2020)
Office lease entered into as of January 10, 2019 with Four Tower Bridge Associates, a Pennsylvania Limited Partnership (Filed With SEC on May 8, 2019)
Sales Agreement, dated November 5, 2020, by and between Madrigal Pharmaceuticals, Inc. and Cowen and Company, LLC (Filed With SEC on November 5, 2020)
Underwriting Agreement, dated December 10, 2019, by and among Madrigal Pharmaceuticals, Inc., the Selling Stockholders, and Goldman Sachs & Co. LLC (Filed With SEC on December 12, 2019)